News
The Annual Conference of Otolaryngology Head and Neck Surgery in Hunan Province Held Coffee to Share Drug Selection under the "Resistance Restriction Order"
On September 24, the academic exchange meeting of the Otolaryngology Committee of Hunan Province was held in the beautiful Yueyang City. The relevant leaders of Yueyang City and experts such as Tian Daofa, chairman of the Otolaryngology Committee of Hunan Society of Integrated Traditional Chinese and Western Medicine, attended the meeting.
報錯 雙語對照
On September 24, the academic exchange meeting of the Otolaryngology Committee of Hunan Province was held in the beautiful Yueyang City. The relevant leaders of Yueyang City and experts such as Tian Daofa, chairman of the Otolaryngology Committee of Hunan Society of Integrated Traditional Chinese and Western Medicine, attended the meeting.
At the opening ceremony, Tian Daofa, chairman of the Otolaryngology Committee of Hunan Integrated Chinese and Western Medicine Society, Liu Gang, chairman of allergy branch of Hunan Integrated Chinese and Western Medicine Society, and Haobo, deputy director of Yueyang Health Planning Committee, made speeches. With the development of science and technology, the treatment of Otorhinolaryngology diseases has entered a "new normal". The emergence of new knowledge, new technology and new drugs puts forward higher requirements for medical staff, and brings new hope for patients to cure diseases.
Wang Xianwen, Director of Otolaryngology Department, First Affiliated Hospital of Hunan University of Traditional Chinese Medicine, delivered an academic lecture on "Drug Selection under Resistance Restriction Order" for the participants. In 2016, the National Action Plan to Curb Bacterial Resistance (2016-2020) was jointly issued by 14 departments such as the Health Planning Commission and the Development and Reform Commission. Under the increasingly stringent use of antimicrobial drugs, traditional Chinese medicine preparations with antimicrobial effects have become a new choice for doctors to treat acute pharyngitis, acute tonsillitis and other pharyngolaryngeal diseases.
Based on many years of clinical experience, Director Wang Xianwen recommended to the participants the Houyanqing Oral Solution produced by Hunan Times Sunshine Pharmaceutical Co., Ltd. for the treatment of acute pharyngitis, acute tonsillitis and other pharyngolaryngeal diseases. Houyanqing Oral Liquid is a national key new product, a national exclusive product, and a national protected variety of traditional Chinese medicine. Professor Wang Xianwen elaborated the characteristics of Houyanqing Oral Liquid from the aspects of prescription composition, prescription, pharmacodynamics, clinical efficacy and safety evaluation, and highlighted the remarkable efficacy of the product in the treatment of throat diseases.
After the introduction of Director Wang Xianwen, the participants showed great interest in Houyanqing Oral Liquid. They carefully read the report of "Time Sunshine Man" on the research of large varieties of Houyanqing Oral Liquid, and came to the exhibition stand of Time Sunshine Pharmaceutical Industry to ask for information and samples.
At the meeting, experts and scholars from Mcmaster University, Shanghai First People's Hospital, Pearl River Hospital, Xiangya Hospital, Hunan University of Traditional Chinese Medicine and other well-known medical and scientific research institutions in China brought academic sharing on different topics to more than 300 guests. Experts, famous doctors and students gathered to discuss difficult cases, share typical cases and exchange clinical experience. This conference has played a great role in promoting academic exchanges, diagnosis and treatment of Otolaryngology diseases in Hunan.
CopyRight@Hunan Times Sunshine Pharmaceutical Co., Ltd.
Record No.：Hunan ICP preparation11019517Number-1
Record No.：Hunan ICP preparation11019517Number-1